Novozymes A/S banner

Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: kr165.6B

P/E

54.8
Current
No historical data
Comparison unavailable

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
54.8
=
Market Cap
kr165.6B
/
Net Income
kr3B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
54.8
=
Market Cap
kr165.6B
/
Net Income
kr3B

Valuation Scenarios

Novozymes A/S is trading above its 3-year average

If P/E returns to its 3-Year Average (54.8), the stock would be worth kr403 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-69%
Maximum Upside
No Upside Scenarios
Average Downside
17%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 54.8 kr403
0%
3-Year Average 54.8 kr403
0%
5-Year Average 54.8 kr403
0%
Industry Average 54.8 kr403
0%
Country Average 17.2 kr126.86
-69%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
kr165.6B
/
Jan 2024
kr3B
=
54.8
Current
kr165.6B
/
Dec 2024
kr521.2m
=
317.7
Forward
kr165.6B
/
Dec 2025
kr573m
=
289
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Peer Comparison

Market Distribution

Higher than 90% of companies in Denmark
Percentile
90th
Based on 404 companies
90th percentile
54.8
Low
4.3 — 12.1
Typical Range
12.1 — 26.5
High
26.5 —
Distribution Statistics
Denmark
Min 4.3
30th Percentile 12.1
Median 17.2
70th Percentile 26.5
Max 2 462.8

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett